Interesting facts
Interesting Facts about (8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl heptanoate
This compound, known for its complex structure, is a fascinating member of a class of organic compounds often referred to as steroids. Here are some intriguing facts regarding its significance and attributes:
- Steroidal Framework: The compound embodies a steroid framework, characterized by its polycyclic structure that contributes to its biological activity.
- Biosynthesis: It may play a role in the biosynthesis of certain hormones, with potential implications in endocrinology and metabolic studies.
- Applications: Compounds with similar structures are often explored for their medicinal properties, particularly in the realms of anti-inflammatory and anabolic agents.
- Research Interest: The unique stereochemistry indicated by the R and S configurations is critical in understanding its interaction with biological systems, influencing how it binds to specific receptors.
- Chirality: The presence of multiple chiral centers makes this molecule a subject of interest in stereochemistry, where the arrangement of atoms can lead to vastly different biological effects.
In summary, the investigation of (8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl heptanoate opens avenues for diverse scientific inquiries, ranging from pharmaceuticals to synthetic organic chemistry. As the landscape of compound research evolves, this molecule stands out as a potential candidate for innovative therapeutic solutions that could improve human health.
Synonyms
testosterone enanthate
315-37-7
Delatestryl
Androtardyl
Testosterone heptanoate
Testosterone enantate
Atlatest
Testanthate
Testinon
Testoenant
Everone
Testosterone heptylate
Exten test
Orquisteron-E
Depo-Testro Med
Andropository
Durathate
Testostroval
Testosterone heptoate
Reposo-TMD
Testosterone oenanthate
Testenate
DePatestrye
Malogen L.A.
Testosterone 17-enanthate
Reposo TMD
Malogen L.A.200
NSC-17591
Testonenant
Testate
Xyosted
Ditate
17-Hydroxyandrost-4-en-3-one, 17-heptanoate
Testosterone, heptanoate
Andro L.A. 200
Heptanoic acid, ester with testosterone
Testosterone ethanate
17beta-Enanthoxyandrost-4-en-3-one
4-Androsten-3-one 17beta-enanthate
17-((1-Oxoheptyl)oxy)androst-4-en-3-one
CCRIS 7082
Delatest
Testosterone enanthate ciii
17beta-Hydroxyandrost-4-en-3-one enanthate
EINECS 206-253-5
Androgyn L.A.
Androst-4-en-3-one, 17-[(1-oxoheptyl)oxy]-, (17b)-
BRN 3170544
CHEBI:9464
UNII-7Z6522T8N9
Androst-4-en-3-one, 17-((1-oxoheptyl)oxy)-, (17beta)-
7Z6522T8N9
Androst-4-en-3-one, 17beta-hydroxy-, heptanoate
Androst-4-en-3-one, 17-(1-oxoheptyl)oxy-, (17beta)-
Testosterone enanthate [USP:JAN]
DTXSID701016540
4-08-00-00979 (Beilstein Handbook Reference)
NSC17591
[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate
3-oxoandrost-4-en-17beta-yl heptanoate
17beta-hydroxyandrost-4-en-3-one heptanoate
Testosterone 17-heptanoate
17-heptanoyl-17beta-hydroxyandrost-4-en-3-one
DITATE-DS COMPONENT TESTOSTERONE ENANTHATE
Testosterone enanthate (USP:JAN)
TESTOSTERONE ENANTATE (MART.)
TESTOSTERONE ENANTATE [MART.]
TESTOSTERONE ENANTHATE (USP-RS)
TESTOSTERONE ENANTHATE [USP-RS]
TESTOSTERONE ENANTATE (EP MONOGRAPH)
TESTOSTERONE ENANTATE [EP MONOGRAPH]
17-[(1-Oxoheptyl)oxy]androst-4-en-3-one
TESTOSTERONE ENANTHATE CIII (USP-RS)
TESTOSTERONE ENANTHATE CIII [USP-RS]
TESTOSTERONE ENANTHATE (USP MONOGRAPH)
TESTOSTERONE ENANTHATE [USP MONOGRAPH]
Primosteston
Androst-4-en-3-one, 17-[(1-oxoheptyl)oxy]-, (17.beta.)-
Testo-Enant
Andro LA
Delatestryl (TN)
Testosteroni enantas
Ditate (Salt/Mix)
Xyosted (Autoinjector)
Deladumone (Salt/Mix)
Testosterone heptoic acid
SCHEMBL42687
Androgyn L.A. (Salt/Mix)
Testosterone 17beta-heptanoate
CHEMBL1200335
Androst-4-en-3-one, heptanoate
DTXCID901474730
Testosterone 17beta-heptanoic acid
TESTOSTERONE ENANTHATE [MI]
Testosterone enanthate (JP17/USP)
TESTOSTERONE ENANTHATE [JAN]
LMST02020075
s3717
Androst-4-en-3-one,(17.beta.)-
TESTOSTERONE ENANTHATE [VANDF]
AKOS015960945
TESTOSTERONE ENANTATE [WHO-IP]
CCG-268655
DB13944
TESTOSTERONE ENANTHATE [WHO-DD]
4-Androsten-3-one 17.beta.-enanthate
(8R,9S,10R,13S,14S,17S)-10,13-Dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl heptanoate
AC-12599
DS-11585
FT158490
Testosterone enanthate, analytical standard
4-Androsten-17beta-ol-3-one 17-enanthate
TESTOSTERONE ENANTHATE [ORANGE BOOK]
TESTOSTERONI ENANTAS [WHO-IP LATIN]
NS00015428
WLN: L E5 B666 OV MUTJ A E FOV6
C08157
D00958
17beta-(HEPTANOYLOXY)ANDROST-4-EN-3-ONE
17-Hydroxyandrost-4-en-3-one, 17-heptanoic acid
SR-01000942262
SR-01000942262-1
TESTOSTERONE ENANTHATE COMPONENT OF DITATE-DS
Androst-4-en-3-one, 17.beta.-hydroxy-, heptanoate
BRD-K89657519-001-01-8
Q27108402
3-Oxoandrost-4-en-17-yl heptanoate, (17.beta.)- #
17.BETA.-(HEPTANOYLOXY)ANDROST-4-EN-3-ONE [WHO-IP]
17- [(1- Oxoheptyl) oxy] - (17?) -androst- 4- en- 3- one
ANDROST-4-EN-3-ONE, 17-(1-OXOHEPTYL)OXY-, (17.BETA.)-
Testosterone enantate, European Pharmacopoeia (EP) Reference Standard
Testosterone enanthate, United States Pharmacopeia (USP) Reference Standard
Testosterone enantate for peak identification, European Pharmacopoeia (EP) Reference Standard
Testosterone enantate for system suitability, European Pharmacopoeia (EP) Reference Standard
206-253-5
Solubility of [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate
The solubility of complex organic compounds like [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate is influenced by various factors, including polarity, functional groups, and the overall molecular structure. Given its intricate structure, one might expect the following characteristics regarding its solubility:
Overall, the solubility behavior of this compound likely reflects a balance between its polar and non-polar properties, emphasizing the need for careful solvent selection based on its unique structure.